Jones Financial Companies
MBX

Jones Financial Companies’s MBX Biosciences MBX Stock Holding History

Jones Financial Companies’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28K Hold
80
– – ﹤0.01% 4115
2025
Q4 		$2.52K Buy
+80
New +$1.94K ﹤0.01% 3754

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Jones Financial Companies's MBX Position: Q1 2026 in Review

Jones Financial Companies held its MBX Biosciences (MBX) position steady in Q1 2026 at 80 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #4115.

Jones Financial Companies first reported a position in MBX in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.52K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Jones Financial Companies held 80 shares of MBX Biosciences worth $2.28K as of Q1 2026.
  • Jones Financial Companies left its MBX Biosciences share count unchanged in Q1 2026.
  • MBX Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4115 holding.
  • Jones Financial Companies first reported a position in MBX Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's MBX Biosciences position peaked at $2.52K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.